Purpose. To complete identification of the major components of the hum
an macular pigment. Methods. Chemical ionization mass spectra of the m
acular pigment components were obtained and compared with those of zea
xanthin and lutein standards. A comparison was also made using chiral
column high-performance liquid chromatography, which is capable of res
olving individual stereoisomers of these carotenoids. Zeaxanthin and l
utein from human blood plasma were similarly analyzed. Results. The ma
ss spectrometry data supported earlier work in which high-performance
liquid chromatography, UV-visible spectrometry and chemical modificati
on showed that the macular pigment comprises two carotenoids with iden
tical properties to those of zeaxanthin and lutein. Chiral column chro
matography showed that the ''zeaxanthin'' fraction is a mixture of two
stereoisomers, zeaxanthin itself [(3R,3'R)-beta,beta-Carotene-3,3'-di
ol] and meso-zeaxanthin [(3R,3'S)-beta,beta-Carotene-3,3'-diol]. The o
ther fraction is the single stereoisomer, lutein [(3R,3'R,6'R)-beta,ep
silon-Carotene-3,3'-diol]. In human blood plasma, only zeaxanthin and
lutein were found. Conclusions. The results strongly suggest that meso
-zeaxanthin results from chemical processes within the retina. Noting
that lutein exceeds zeaxanthin in plasma but that the combined zeaxant
hin stereoisomers exceed lutein in the retina, the possibility was con
sidered that meso-zeaxanthin is a conversion product derived from reti
nal lutein. Under nonphysiologic conditions, the authors demonstrate t
hat a base-catalyzed conversion of lutein to zeaxanthin yields only th
e meso-(3R,3'S) stereoisomer.